Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06524232
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-23
Brief Title:
The STop UNhealthy Substance Use Now Trial
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The STop UNhealthy Substance Use Now Trial
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STUN II
Brief Summary:
The STop UNhealthy STUN Substance Use Now Trial STUN II is a multisite trial aiming to evaluate the comparative effectiveness of the following strategies for improving the implementation of screening and interventions for substance use disorders in primary care practice facilitation PF PF plus a learning collaborative LC PF plus performance incentives PI and PFLCPI We plan to enroll 144 clinic staff participants from 48 primary care practices
Detailed Description:
The STop UNhealthy STUN Substance Use Now Trial STUN II is a multisite trial aiming to evaluate the comparative effectiveness of the following strategies for improving the implementation of screening and interventions for substance use disorders in primary care practice facilitation PF PF plus a learning collaborative LC PF plus performance incentives PI and PFLCPI We plan to enroll 144 clinic staff participants from 48 primary care practices
Specific aim 1 primary aim will compare the effect of learning collaborative LC participation performance incentives PI or their combination with practice facilitation PF only on implementation of evidence-based screening for SUDs
Specific aim 2 secondary aim will compare the effect of LC participation PI or their combination with PF only on implementation of evidence-based interventions for SUDs including a brief counseling b medications eg buprenorphine naltrexone and adherence to them and c referral to specialty care
Specific aims 1 and 2 will produce fundamentally important evidence about the comparative effectiveness of PF PFLC PFPI and PFLCPI strategies on uptake of evidence-based screening and interventions for SUD when delivered to primary care practices
Specific aim 3 exploratory aim will use a longitudinal mixed-methods evaluation to assess the association between implementation effectiveness and putative moderators eg organizational readiness for change and mediators eg implementation climate Aim 3 will generate scientific knowledge about mechanisms of change why and how the various strategies work in primary care settings
Specific aim 1 primary aim will compare the effect of learning collaborative LC participation performance incentives PI or their combination with practice facilitation PF only on implementation of evidence-based screening for SUDs
Specific aim 2 secondary aim will compare the effect of LC participation PI or their combination with PF only on implementation of evidence-based interventions for SUDs including a brief counseling b medications eg buprenorphine naltrexone and adherence to them and c referral to specialty care
Specific aims 1 and 2 will produce fundamentally important evidence about the comparative effectiveness of PF PFLC PFPI and PFLCPI strategies on uptake of evidence-based screening and interventions for SUD when delivered to primary care practices
Specific aim 3 exploratory aim will use a longitudinal mixed-methods evaluation to assess the association between implementation effectiveness and putative moderators eg organizational readiness for change and mediators eg implementation climate Aim 3 will generate scientific knowledge about mechanisms of change why and how the various strategies work in primary care settings
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None